BOSTON SCIENTIFIC CORPORATION Payments for Hedge, Investing Activities
BOSTON SCIENTIFIC CORPORATION (BSX) reported Payments for Hedge, Investing Activities of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForHedgeInvestingActivities · last filed 2021-02-23
- BOSTON SCIENTIFIC CORPORATION payments for hedge, investing activities for the quarter ending 2020-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for hedge, investing activities for the quarter ending 2019-12-31 was -$95.00M.
- BOSTON SCIENTIFIC CORPORATION payments for hedge, investing activities for the quarter ending 2018-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for hedge, investing activities for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- BOSTON SCIENTIFIC CORPORATION payments for hedge, investing activities for fiscal 2019 was $199.00M.
- BOSTON SCIENTIFIC CORPORATION payments for hedge, investing activities for fiscal 2018 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for hedge, investing activities for fiscal 2017 was $0.00.
| Period end | Payments for Hedge, Investing Activities 3 month | Payments for Hedge, Investing Activities 9 month | Payments for Hedge, Investing Activities 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | ||
| 2019-12-31 | -$95.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $199.00M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $294.00M 10-Q · filed 2020-11-05 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-05 | ||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |